Abstract
This study was undertaken to evaluate the efficiency of a trabecular micro-bypass stent designed to allow direct aqueous drainage from the anterior chamber into Schlemm’s canal in patients with glaucoma. In this prospective case series of 6 patients with open-angle glaucoma, the microstent was inserted ab interno under local anesthesia in an ophthalmic operating room. Patients were seen postoperatively at 1 to 2 d, 1 wk, and 1, 2, 6, and 12 mo. All stents were successfully placed within Schlemm’s canal. Mean intraocular pressure (IOP) at preoperative baseline was 20.2±6.3 mm Hg (range, 14–31 mm Hg). Mean IOP decreased during the immediate postoperative period to approximately 12 to 13 mm Hg and was stabilized at 14 to 15 mm Hg with reduction of medication throughout 1 y of follow-up. No major complications occurred. According to observations reported in this feasibility study, the microstent was effective in reducing IOP and in decreasing the number of glaucoma medications required to control IOP. Implantation procedures were safe, and stents remained in place throughout the follow-up period. None of the complications traditionally associated with filtering surgery were reported. Further research on this stent in a larger group of patients is needed to assess its role in glaucoma therapy.
Similar content being viewed by others
References
Preferred Practice Pattern: Primary Open-Angle Glaucoma. San Francisco, Calif: American Academy of Ophthalmology; 2003:1-36.
Terminology and Guidelines for Glaucoma. Savona, Italy; European Glaucoma Society; 2003.
Migdal C, Gregory W, Hitchings R. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma.Ophthalmology. 1994;101:1651–1656; discussion 1657.
Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery.Ophthalmology. 2001;108:1943–1953.
Deokule S, Sadiq S, Shah S. Chronic open angle glaucoma: patient awareness of the nature of the disease, topical medication, compliance and the prevalence of systemic symptoms.Ophthalmic Physiol Opt. 2004;24:9–15.
Gurwitz JH, Yeomans SM, Lewis B, et al. Treatment for glaucoma: adherence by older persons in managed care.Clin Pharmacol Ther. 1996;59:172.
Urquhart J, Bell J, Metry J-M. Meta-analysis of reported study with micro-electronic monitoring of patient compliance.J Clin Res Drug Develop. 1989;3:227.
Kass MA, Gordon M, Morley RE Jr, Meltzer DW, Goldberg JJ. Compliance with topical timolol treatment.Am J Ophthalmol. 1987;103:188–193.
Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J. Compliance with topical pilocarpine treatment.Am J Ophthalmol. 1986;101:515–523.
Broadway DC, Grierson I, Sturmer J, Hitchings RA. Reversal of topical antiglaucoma medication effects on the conjunctiva.Arch Ophthalmol. 1996;114:262–267.
Asrani S, Zeimer R, Wilensky J, Gieser D, Vitale S, Lindenmuth K. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma.J Glaucoma. 2000; 9:134–142.
Cairns JE. Trabeculectomy: preliminary report of a new method.Am J Ophthalmol. 1968;66:673–679.
Addicks EM, Quigley HA, Green WR, Robin AL. Histologic characteristics of filtering blebs in glaucomatous eyes.Arch Ophthalmol. 1983;101:795–798.
Schwartz AL, Anderson DR. Trabecular surgery.Arch Ophthalmol. 1974;92:134–138.
Budenz DL, Hoffman K, Zacchei A. Glaucoma filtering bleb dysesthesia.Am J Ophthalmol. 2001; 131:626–630.
Stegmann R, Pienaar A, Miller D. Viscocanalostomy for open-angle glaucoma in black African patients.J Cataract Refract Surg. 1999;25:316–322.
Mermoud A, Schnyder CC, Sickenberg M, Chiou AG, Hediquer SE, Faggioni R. Comparison of deep sclerectomy with collagen implant and trabeculectomy in open-angle glaucoma.J Cataract Refract Surg. 1999;25:323–331.
El Sayyad F, Helal M, El-Kholify H, Khalil M, El-Maghraby A. Nonpenetrating deep sclerectomy versus trabeculectomy in bilateral primary open-angle glaucoma.Ophthalmology. 2000;107: 1671–1674.
Sunaric-Megevand G, Leuenberger PM. Results of viscocanalostomy for primary open-angle glaucoma.Am J Ophthalmol. 2001;132:221–228.
Carassa RG, Bettin P, Fiori M, Brancato R. Viscocanalostomy: a pilot study.Eur J Ophthalmol. 1998;8:57–61.
Drusedau MU, von Wolff K, Bull H, von Barsewisch B. Viscocanalostomy for primary openangle glaucoma: the Gross Pankow experience.J Cataract Refract Surg. 2000;26:1367–1373.
Jonescu-Cuypers CP, Jacobi PC, Konen W, Krieglstein GK. Primary viscocanalostomy versus trabeculectomy in white patients with open-angle glaucoma: a randomized clinical trial.Ophthalmology. 2001;108:254–258.
Spiegel D, Kobuch K. Trabecular meshwork bypass tube shunt: initial case series.Br J Ophthalmol. 2002;86:1228–1231.
Bahler CK, Smedley GT, Zhou J, Johnson DH. Trabecular bypass stents decrease intraocular pressure in cultured human anterior segments.Am J Ophthalmol. 2004;138:988–994.
Zhou J, Smedley GT. A trabecular bypass flow hypothesis.J Glaucoma. 2005;14:74–83.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Spiegel, D., Wetzel, W., Haffner, D.S. et al. Initial clinical experience with the trabecular micro-bypass stent in patients with glaucoma. Adv Therapy 24, 161–170 (2007). https://doi.org/10.1007/BF02850004
Issue Date:
DOI: https://doi.org/10.1007/BF02850004